pyrotinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Unknown (1)

Interventional (1)
Observational (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Shanghai Jiao Tong University School of Medicine (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadbreast cancer

I am/have/hadher2+ breast cancer

I am/have/hadprogesterone

I am/have/hadplatelet count

I am/have/hadabsolute neutrophil count

I am/have/hadmetastasis

I am/have/hadgene amplification

I am/have/hadejection fraction

I am/have/hadinvasive breast cancer

I am/have/hadliver metastasis

I am/have/hadprogesterone receptor

I am/have/hadbreast cancer stage

I am/have/hadher2 gene amplification

I am/have/hadestrogen receptor

I am/have/hadestrogen

I am/have/hadadjuvant therapy

I am/have/hadimmunohistochemistry

I am/have/had12 lead electrocardiogram

I am/have/haderbb2 gene amplification

I am/have/hadHER2

added new label for I am/have/had

more

I am looking for

I am looking forpyrotinib

I am looking fortrastuzumab

I am looking forher-2

I am looking forprogesterone

I am looking forestrogen

I am looking forpertuzumab

I am looking foremtansine

I am looking forpaclitaxel

I am looking forerbb2

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Pyrotinib Trastuzumab Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

This study aims to evaluate the efficacy and safety of pyrotinib in combination with trastuzumab, pertuzumab and nab-paclitaxel as neoadjuvant therapy in early stage or locally advanced HER2-positive breast cancer.

her2+ breast cancer

progesterone receptor

her2 positive breast carcinoma

gene amplification

pyrotinib

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Family Medicine
Recruiting

A Clinical Study of Pyrotinib in Patients of Advanced Colorectal Cancer With Her2 Variation

To Observe the Efficacy and Safety of Pyrotinib Maleate in Patients With Advanced HER2 Variation Colorectal Cancer

12 lead electrocardiogram

neutrophil count

pyrotinib

blood transfusion

colorectal cancer

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.